Bragg Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

Bragg Financial Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,578	Closed	-$202K	–	319
2022 Q1	$202K	Sell	1,578 -15	-0.9%	-$1.81K	0.01%	312
2021 Q4	$226K	Hold	1,593	–	–	0.01%	288
2021 Q3	$226K	Buy	1,593 +51	+3%	+$7.5K	0.01%	288
2021 Q2	$241K	Buy	+1,542	New	+$250K	0.02%	286
2020 Q1	–	Sell	-1,402	Closed	-$204K	–	278
2019 Q4	$204K	Buy	+1,402	New	+$194K	0.02%	261

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bragg Financial Advisors's ZBH Position: Q2 2022 in Review

Bragg Financial Advisors sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 1,578 shares — an estimated $202K sold.

Bragg Financial Advisors first reported a position in ZBH in Q4 2019 and held it in 5 quarters. The position peaked at $241K in Q2 2021. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

Bragg Financial Advisors reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
Bragg Financial Advisors sold 1,578 Zimmer Biomet shares in Q2 2022, an estimated $202K.
Bragg Financial Advisors first reported a position in Zimmer Biomet in Q4 2019 and held it in 5 quarters.
Bragg Financial Advisors's Zimmer Biomet position peaked at $241K in Q2 2021.
956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Bragg Financial Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.